Extras

Vijyoti and TEM International enter exclusive alliance to introduce Patient Blood Management enabling technologies in India

New Delhi, April 05, 2016: Vijyoti, India’s leading corporate social enterprise with specialization in innovation management in the pharma and education sector has partnered with TEM International, a leading German medical technology company that is redefining bleeding control through its proprietary ROTEM® (Rotational Thromboelastometry) point-of-care diagnostic equipment to introduce cutting edge solutions for patient blood management in India.

ROTEM – The Optimal Haemostasis Analyser is the first choice solution for doctors globally in detecting, managing and monitoring haemostasis in cardiac surgery, liver transplant. obsetrics and trauma patients. The analyzer provides precise results within 5-10 minutes, whereas standard laboratory testing takes up to 40-60 minutes. The technology allows for targeted therapy to be provided at the point-of-care (POC).

Speaking on the occasion of India’s first National Symposium on Innovations in Bleeding Management, Dr. Klaus Goerlinger, Senior Consultant for Anaesthesiology, Intensive Care and Emergency Medicine, University Duisburg-Essen, Germany, said:. “Bleeding and blood transfusion have been shown to be independent risk factors for increased morbidity and mortality. Our collaboration with Vijyoti will help introduce ROTEM as an integral technology to patient blood management in India, one that will allow for point-of-care decisions for blood transfusion to be the last resort and not the first option to manage bleeding.”

Speaking on the occasion Mr. Vijay Pande, Managing Director, Vijyoti, said, “Despite being a country with a population of 1.2 billion, India faces a blood shortage of three million units annually. Patient blood management demands a change in the mindset towards bleeding management. Entering into the healthcare segment through our alliance with TEM International, Vijyoti is immensely honoured to introduce ROTEM to India and promote blood conservation with benefit to the patient, the blood banks and hospitals by enabling efficient and economical use of this increasingly scarce, expensive resource.”

ROTEM conducts four tests simultaneously – EXTEM, INTEM, FIBTEM and APTEM/HEPTEM. The easy-to-use portable device comes with a powerful intuitive software package and a sophisticated data handling system. The database stores all results and can be easily exported into MS Excel or other software for further processing.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

1 day ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

2 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

3 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

4 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

1 week ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420